CEREGENE

Details for Australian Trade Mark No. 874392 (hide)

Owner Ceregene, Inc. a Delaware corporation

Service Spruson & Ferguson

Various Convention priority claimed: 3 November 2000, United States of America, No. 76/159273 in respect of VIRAL SYSTEM, NAMELY, VIRAL VECTORS, PACKAGING CELLS AND CELLS TRANSFORMED WITH VIRAL VECTORS FOR THERAPEUTIC AND CLINICAL USE FOR THE TREATMENT OF AUTOIMM

Classes

Class 5 Pharmaceutical preparations and substances; viral system, including viral vectors, packaging cells and cells transformed with viral vectors for therapeutic and clinical use for the treatment of autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases and diseases of the central and peripheral nervous systems; excluding hair and scalp preparations

Class 42 Research and product development services concerning biotechnology

Event Publications

26 May 2011 Renewal of Registration/IR

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

874393-NORVAX

874391-LOOK TO BOOK